STRIDES PHARMA SCIENCE
|
STRIDES PHARMA SCIENCE Last 5 Year Income Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹6,250 Cr | ₹6,245 Cr | ₹5,327 Cr | ₹5,473 Cr | ₹4,711 Cr |
Sales | ₹6,028 Cr | ₹6,100 Cr | ₹5,213 Cr | ₹5,372 Cr | ₹4,600 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | ₹62 Cr | ₹65 Cr | ₹66 Cr | ₹36 Cr | ₹16 Cr |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹160 Cr | ₹81 Cr | ₹48 Cr | ₹65 Cr | ₹95 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹4,051 Cr | ₹3,688 Cr | ₹3,070 Cr | ₹3,316 Cr | ₹2,752 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹16 Cr | ₹-2.67 Cr | ₹95 Cr | ₹-354 Cr | ₹-45 Cr |
Raw Material Consumed | ₹1,625 Cr | ₹1,630 Cr | ₹1,407 Cr | ₹1,686 Cr | ₹1,167 Cr |
Opening Raw Materials | ₹522 Cr | ₹575 Cr | ₹552 Cr | ₹507 Cr | ₹415 Cr |
Purchases Raw Materials | ₹1,326 Cr | ₹1,389 Cr | ₹1,114 Cr | ₹1,435 Cr | ₹1,112 Cr |
Closing Raw Materials | ₹507 Cr | ₹522 Cr | ₹575 Cr | ₹552 Cr | ₹507 Cr |
Other Direct Purchases / Brought in cost | ₹283 Cr | ₹188 Cr | ₹316 Cr | ₹296 Cr | ₹147 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹86 Cr | ₹86 Cr | ₹72 Cr | ₹65 Cr | ₹64 Cr |
Electricity & Power | ₹86 Cr | ₹86 Cr | ₹72 Cr | ₹65 Cr | ₹64 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹751 Cr | ₹732 Cr | ₹647 Cr | ₹550 Cr | ₹443 Cr |
Salaries, Wages & Bonus | ₹636 Cr | ₹594 Cr | ₹528 Cr | ₹466 Cr | ₹375 Cr |
Contributions to EPF & Pension Funds | ₹55 Cr | ₹60 Cr | ₹55 Cr | ₹39 Cr | ₹32 Cr |
Workmen and Staff Welfare Expenses | ₹59 Cr | ₹76 Cr | ₹64 Cr | ₹38 Cr | ₹34 Cr |
Other Employees Cost | ₹1.59 Cr | ₹1.30 Cr | ₹-0.71 Cr | ₹6.80 Cr | ₹1.75 Cr |
Other Manufacturing Expenses | ₹315 Cr | ₹259 Cr | ₹256 Cr | ₹238 Cr | ₹211 Cr |
Sub-contracted / Out sourced services | ₹57 Cr | ₹45 Cr | ₹48 Cr | ₹45 Cr | ₹34 Cr |
Processing Charges | - | - | - | - | - |
Repairs and Maintenance | ₹169 Cr | ₹131 Cr | ₹111 Cr | ₹89 Cr | ₹77 Cr |
Packing Material Consumed | - | - | - | - | - |
Other Mfg Exp | ₹88 Cr | ₹83 Cr | ₹96 Cr | ₹104 Cr | ₹100 Cr |
General and Administration Expenses | ₹253 Cr | ₹232 Cr | ₹224 Cr | ₹192 Cr | ₹192 Cr |
Rent , Rates & Taxes | ₹78 Cr | ₹67 Cr | ₹60 Cr | ₹66 Cr | ₹48 Cr |
Insurance | ₹18 Cr | ₹26 Cr | ₹21 Cr | ₹17 Cr | ₹13 Cr |
Printing and stationery | ₹3.51 Cr | ₹4.16 Cr | ₹3.61 Cr | ₹4.19 Cr | ₹4.50 Cr |
Professional and legal fees | ₹127 Cr | ₹108 Cr | ₹119 Cr | ₹87 Cr | ₹100 Cr |
Traveling and conveyance | ₹16 Cr | ₹14 Cr | ₹9.11 Cr | ₹6.28 Cr | ₹16 Cr |
Other Administration | ₹10 Cr | ₹15 Cr | ₹12 Cr | ₹11 Cr | ₹9.57 Cr |
Selling and Distribution Expenses | ₹225 Cr | ₹264 Cr | ₹331 Cr | ₹223 Cr | ₹137 Cr |
Advertisement & Sales Promotion | ₹37 Cr | ₹22 Cr | ₹18 Cr | ₹13 Cr | ₹11 Cr |
Sales Commissions & Incentives | ₹10 Cr | ₹17 Cr | ₹13 Cr | ₹9.78 Cr | ₹5.58 Cr |
Freight and Forwarding | ₹178 Cr | ₹225 Cr | ₹301 Cr | ₹200 Cr | ₹120 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | - | - | - | - | - |
Miscellaneous Expenses | ₹47 Cr | ₹103 Cr | ₹61 Cr | ₹89 Cr | ₹67 Cr |
Bad debts /advances written off | - | - | - | ₹9.46 Cr | ₹11 Cr |
Provision for doubtful debts | ₹18 Cr | ₹34 Cr | - | - | - |
Losson disposal of fixed assets(net) | - | - | - | - | ₹5.31 Cr |
Losson foreign exchange fluctuations | - | - | ₹9.78 Cr | - | ₹19 Cr |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹29 Cr | ₹69 Cr | ₹51 Cr | ₹79 Cr | ₹31 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹3,318 Cr | ₹3,303 Cr | ₹3,092 Cr | ₹2,689 Cr | ₹2,236 Cr |
Operating Profit (Excl OI) | ₹733 Cr | ₹385 Cr | ₹-22 Cr | ₹627 Cr | ₹516 Cr |
Other Income | ₹50 Cr | ₹135 Cr | ₹133 Cr | ₹59 Cr | ₹53 Cr |
Interest Received | ₹30 Cr | ₹75 Cr | ₹107 Cr | ₹35 Cr | ₹37 Cr |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | ₹1.43 Cr | ₹4.11 Cr | ₹11 Cr | ₹2.34 Cr | - |
Profits on sale of Investments | ₹0.79 Cr | ₹0.02 Cr | ₹0.29 Cr | ₹1.19 Cr | ₹4.52 Cr |
Provision Written Back | ₹0.08 Cr | ₹0.84 Cr | ₹1.41 Cr | ₹0.75 Cr | - |
Foreign Exchange Gains | ₹9.64 Cr | ₹45 Cr | - | ₹8.02 Cr | - |
Others | ₹8.27 Cr | ₹11 Cr | ₹13 Cr | ₹12 Cr | ₹12 Cr |
Operating Profit | ₹783 Cr | ₹521 Cr | ₹112 Cr | ₹686 Cr | ₹569 Cr |
Interest | ₹314 Cr | ₹261 Cr | ₹177 Cr | ₹150 Cr | ₹156 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | ₹254 Cr | ₹198 Cr | ₹129 Cr | ₹109 Cr | ₹120 Cr |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹42 Cr | ₹44 Cr | ₹31 Cr | ₹26 Cr | ₹21 Cr |
Other Interest | ₹18 Cr | ₹20 Cr | ₹17 Cr | ₹15 Cr | ₹15 Cr |
PBDT | ₹469 Cr | ₹259 Cr | ₹-65 Cr | ₹536 Cr | ₹413 Cr |
Depreciation | ₹221 Cr | ₹243 Cr | ₹233 Cr | ₹206 Cr | ₹174 Cr |
Profit Before Taxation & Exceptional Items | ₹248 Cr | ₹16 Cr | ₹-298 Cr | ₹330 Cr | ₹240 Cr |
Exceptional Income / Expenses | ₹-189 Cr | ₹-17 Cr | ₹-244 Cr | ₹43 Cr | ₹-78 Cr |
Profit Before Tax | ₹-117 Cr | ₹-286 Cr | ₹-653 Cr | ₹275 Cr | ₹55 Cr |
Provision for Tax | ₹32 Cr | ₹-55 Cr | ₹-178 Cr | ₹32 Cr | ₹11 Cr |
Current Income Tax | ₹50 Cr | ₹20 Cr | ₹10 Cr | ₹29 Cr | ₹28 Cr |
Deferred Tax | ₹-16 Cr | ₹-24 Cr | ₹-17 Cr | ₹9.58 Cr | ₹-32 Cr |
Other taxes | ₹-1.86 Cr | ₹-52 Cr | ₹-172 Cr | ₹-6.94 Cr | ₹15 Cr |
Profit After Tax | ₹-149 Cr | ₹-231 Cr | ₹-474 Cr | ₹244 Cr | ₹43 Cr |
Extra items | ₹54 Cr | ₹19 Cr | - | ₹14 Cr | ₹-13 Cr |
Minority Interest | ₹24 Cr | ₹9.70 Cr | ₹14 Cr | ₹11 Cr | ₹5.80 Cr |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹-71 Cr | ₹-203 Cr | ₹-460 Cr | ₹268 Cr | ₹36 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹-200 Cr | ₹2.31 Cr | ₹485 Cr | ₹234 Cr | ₹381 Cr |
Appropriations | ₹-271 Cr | ₹-200 Cr | ₹25 Cr | ₹503 Cr | ₹417 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | ₹18 Cr |
Other Appropriation | ₹14 Cr | - | ₹22 Cr | ₹18 Cr | ₹58 Cr |
Equity Dividend % | ₹25.00 | ₹15.00 | - | ₹25.00 | ₹140.00 |
Earnings Per Share | ₹-7.68 | ₹-22.44 | ₹-51.25 | ₹29.93 | ₹4.06 |
Adjusted EPS | ₹-7.68 | ₹-22.44 | ₹-51.25 | ₹29.93 | ₹4.06 |
Compare Income Statement of peers of STRIDES PHARMA SCIENCE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
STRIDES PHARMA SCIENCE | ₹6,049.7 Cr | -0.7% | -55.5% | 6.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹451,603.0 Cr | 2.9% | 6.4% | 48.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,862.0 Cr | 0.5% | -2.1% | 59.2% | Stock Analytics | |
CIPLA | ₹122,810.0 Cr | 2.3% | 1% | 20.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹114,946.0 Cr | 3.5% | 15.7% | 20.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,377.1 Cr | -0.1% | 2.3% | 41.1% | Stock Analytics |
STRIDES PHARMA SCIENCE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
STRIDES PHARMA SCIENCE | -0.7% |
-55.5% |
6.4% |
SENSEX | 0.3% |
-2.5% |
10% |
You may also like the below Video Courses